ニコチンアミドアデニンジヌクレオチド製品市場規模、成長と動向分析レポート 2025-2033年

ニコチンアミドアデニンジヌクレオチド製品市場 – 製品（経口サプリメント、外用剤）、流通チャネル（ハイパーマーケット＆スーパーマーケット、薬局＆ドラッグストア）、地域、セグメント別予測による市場規模、成長と動向分析レポート 2025-2033年

世界のニコチンアミドアデニンジヌクレオチド製品市場規模は、2024年に34億5,116万米ドルと評価され、2025年から2033年にかけて年平均成長率15.1%で成長し、2033年には121億8,724万米ドルに達すると予想されています。ニコチンアミドアデニンジヌクレオチド（NAD）製品業界は、細胞エネルギー産生、DNA修復、健康的な老化におけるその役割に対する認識の高まりによって推進されています。

長寿と予防的な健康への関心が高まる中、消費者は活力、認知機能、そして代謝の健康をサポートするサプリメントを求めています。さらに、NADレベルと加齢に伴う疾患との関連性を示す継続的な研究は、栄養補助食品およびウェルネス市場における需要をさらに刺激しています。

このレポートは、世界、地域、国レベルでの収益成長を予測し、2021年から2033年までの各サブセグメントにおける最新の業界動向と機会の分析を提供します。この調査のために、Grand View Researchは、製品、流通チャネル、および地域に基づいて、世界のニコチンアミドアデニンジヌクレオチド製品市場レポートをセグメント化しました。

Nicotinamide Adenine Dinucleotide Products Market Summary

The global nicotinamide adenine dinucleotide products market size was valued at USD 3,451.16 million in 2024 and is expected to reach USD 12,187.24 million by 2033, growing at a CAGR of 15.1% from 2025 to 2033. The nicotinamide adenine dinucleotide (NAD) products industry is driven by increasing awareness of its role in cellular energy production, DNA repair, and healthy aging.

Consumers are seeking supplements that support vitality, cognitive function, and metabolic health, especially as interest in longevity and preventive wellness grows. Additionally, ongoing research linking NAD levels to age-related conditions has further fueled demand in the nutraceutical and wellness markets.

The popularity of NAD-boosting supplements like NR (Nicotinamide Riboside) and NMN (Nicotinamide Mononucleotide) has increased, driven by interest in healthy aging and cognitive support. Brands such as Tru Niagen and Elysium Health have capitalized on this trend, offering products that claim to enhance energy, focus, and resilience against age-related decline.

NAD products are also seeing wider use beyond supplements, appearing in IV therapy, skincare, and functional beverages, making them more accessible and appealing to a broader audience. As clinical research and consumer demand continue to grow, NAD is becoming a key ingredient in the evolving wellness and anti-aging space. For instance, in May 2025, Eden, a leading metabolic health platform, launched U.S.-wide access to a prescription-only NAD+ 10% Face Cream through its telehealth service.

The NAD products industry is expanding well beyond traditional oral supplements, with brands exploring new delivery formats to improve efficacy, user experience, and market appeal. While capsules and tablets containing precursors like Nicotinamide Riboside (NR) and Nicotinamide Mononucleotide (NMN) remain the most common format, newer options such as liposomal formulations, sustained-release tablets, and sublingual powders are gaining popularity for their potential to enhance bioavailability. These innovations not only cater to consumer demand for more effective dosing but also allow brands to differentiate in a crowded market.

For instance, in January 2025, Renue by Science introduced a new skincare line called Renue Blue, which focuses on skin wellness and longevity through the use of liposomal NAD (Nicotinamide Adenine Dinucleotide). The product line aims to leverage the benefits of NAD, a coenzyme crucial for cellular functions, in a topical format to promote skin health. The liposomal delivery system is designed to enhance the absorption and effectiveness of NAD in the skin.

Nicotinamide Adenine Dinucleotide Products Market Report Scope

Nicotinamide Adenine Dinucleotide Products Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global nicotinamide adenine dinucleotide products market report on the basis of product, distribution channel, and region.

• Product Outlook (Revenue, USD Million, 2021 – 2033)
• Oral Supplements

o Capsules/Tablets

o Powders

o Energy Drinks

• Topical Products

o Creams & Serums

o Eye Cream & Lip Balms

• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 – 2033)
• Hypermarkets & Supermarkets
• Pharmacies & Drug Stores
• Online
• Others
• Regional Outlook (Revenue, USD Million, 2021 – 2033)
• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Italy

o Spain

• Asia Pacific

o China

o India

o Japan

o Australia & New Zealand

o Taiwan

o South Korea

• Central & South America

o Brazil

• Middle East & Africa

o UAE

Table of Contents

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Market Definition

1.3. Information Procurement

1.3.1. Purchased Database

1.3.2. GVR’s Internal Database

1.3.3. Secondary Materials & Third-Party Perspectives

1.3.4. Primary Research

1.4. Information Analysis

1.4.1. Data Analysis Models

1.5. Market Formulation & Data Visualization

1.6. Data Validation & Publishing

Chapter 2. Executive Summary

2.1. Market Snapshot

2.2. Product Outlook

2.3. Distribution Channel Outlook

2.4. Regional Outlook

2.5. Competitive Landscape Snapshot

Chapter 3. Nicotinamide Adenine Dinucleotide (NAD) Products Market Variables and Trends

3.1. Market Introduction

3.2. Industry Value Chain Analysis

3.2.1. Raw Material Trends & Outlook

3.2.2. Retail/Sales Channel Analysis

3.3. Market Dynamics

3.3.1. Market Driver Analysis

3.3.2. Market Restraint Analysis

3.3.3. Market Opportunities

3.3.4. Market Challenges

3.4. Industry Analysis Tools

3.4.1. Porter’s Five Forces Analysis

3.5. Market Entry Strategies

Chapter 4. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Consumer Behavior Analysis

4.1. Demographic Analysis

4.2. Consumer Trends & Preferences

4.3. Factors Affecting Buying Decisions

4.4. Consumer Product Adoption

4.5. Observations & Recommendations

Chapter 5. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Product Estimates & Trend Analysis

5.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Product: Key Takeaways

5.2. Product Movement Analysis & Market Share, 2024 & 2033

5.3. Market Estimates & Forecasts by Product, 2021 – 2033 (USD Million)

5.3.1. Oral Supplements

5.3.1.1. Market estimates and forecast, 2021 – 2033 (USD Million)

5.3.1.1.1. Capsules/Tablets

5.3.1.1.1.1. Market estimates and forecast, 2021 – 2033 (USD Million)

5.3.1.1.2. Powders

5.3.1.1.2.1. Market estimates and forecast, 2021 – 2033 (USD Million)

5.3.1.1.3. Energy Drinks

5.3.1.1.3.1. Market estimates and forecast, 2021 – 2033 (USD Million)

5.3.2. Topical Products

5.3.2.1. Market estimates and forecast, 2021 – 2033 (USD Million)

5.3.2.1.1. Creams & Serums

5.3.2.1.1.1. Market estimates and forecast, 2021 – 2033 (USD Million)

5.3.2.1.2. Eye Cream & Lip Balms

5.3.2.1.2.1. Market estimates and forecast, 2021 – 2033 (USD Million)

5.3.3. Others

5.3.3.1. Market estimates and forecast, 2021 – 2033 (USD Million)

Chapter 6. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Distribution Channel Estimates & Trend Analysis

6.1. Nicotinamide Adenine Dinucleotide (NAD) Products Market, By Distribution Channel: Key Takeaways

6.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2033

6.3. Market Estimates & Forecasts, by Distribution Channel, 2021 – 2033 (USD Million)

6.3.1. Hypermarkets & Supermarkets

6.3.1.1. Market estimates and forecast, 2021 – 2033 (USD Million)

6.3.2. Pharmacies & Drug Stores

6.3.2.1. Market estimates and forecast, 2021 – 2033 (USD Million)

6.3.3. Online

6.3.3.1. Market estimates and forecast, 2021 – 2033 (USD Million)

6.3.4. Others

6.3.4.1. Market estimates and forecast, 2021 – 2033 (USD Million)

Chapter 7. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Regional Estimates & Trend Analysis

7.1. Regional Movement Analysis & Market Share, 2024 & 2033

7.2. North America

7.2.1. U.S.

7.2.1.1. Key country dynamics

7.2.1.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.2.2. Canada

7.2.2.1. Key country dynamics

7.2.2.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.2.3. Mexico

7.2.3.1. Key country dynamics

7.2.3.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.3. Europe

7.3.1. U.K.

7.3.1.1. Key country dynamics

7.3.1.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.3.2. Germany

7.3.2.1. Key country dynamics

7.3.2.2. Key country dynamics

7.3.2.3.Market estimates and forecast, 2021 – 2033 (USD Million)

7.3.3. France

7.3.3.1. Key country dynamics

7.3.3.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.3.4. Italy

7.3.4.1. Key country dynamics

7.3.4.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.3.5. Spain

7.3.5.1. Key country dynamics

7.3.5.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.4. Asia Pacific

7.4.1. China

7.4.1.1. Key country dynamics

7.4.1.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.4.2. India

7.4.2.1. Key country dynamics

7.4.2.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.4.3. Japan

7.4.3.1. Key country dynamics

7.4.3.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.4.4. Australia & New Zealand

7.4.4.1. Key country dynamics

7.4.4.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.4.5. Taiwan

7.4.5.1. Key country dynamics

7.4.5.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.4.6. South Korea

7.4.6.1. Key country dynamics

7.4.6.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.5. Central & South America

7.5.1. Brazil

7.5.1.1. Key country dynamics

7.5.1.2. Market estimates and forecast, 2021 – 2033 (USD Million)

7.6. Middle East & Africa

7.6.1. UAE

7.6.1.1. Key country dynamics

7.6.1.2. Market estimates and forecast, 2021 – 2033 (USD Million)

Chapter 8. Nicotinamide Adenine Dinucleotide (NAD) Products Market: Competitive Analysis

8.1. Recent Developments & Impact Analysis by Key Market Participants

8.2. Company Categorization

8.3. Participant’s Overview

8.4. Financial Performance

8.5. Product Benchmarking

8.6. Company Market Share Analysis, 2024 (%)

8.7. Company Heat Map Analysis, 2024

8.8. Strategy Mapping

8.9. Company Profiles

8.9.1. Core Med Science

8.9.1.1. Company Overview

8.9.1.2. Financial Performance

8.9.1.3. Product Portfolios

8.9.1.4. Strategic Initiatives

8.9.2. Niagen Bioscience, Inc.

8.9.2.1. Company Overview

8.9.2.2. Financial Performance

8.9.2.3. Product Portfolios

8.9.2.4. Strategic Initiatives

8.9.3. Elysium Health

8.9.3.1. Company Overview

8.9.3.2. Financial Performance

8.9.3.3. Product Portfolios

8.9.3.4. Strategic Initiatives

8.9.4. Thorne

8.9.4.1. Company Overview

8.9.4.2. Financial Performance

8.9.4.3. Product Portfolios

8.9.4.4. Strategic Initiatives

8.9.5. Cata-Kor NAD

8.9.5.1. Company Overview

8.9.5.2. Financial Performance

8.9.5.3. Product Portfolios

8.9.5.4. Strategic Initiatives

8.9.6. Life Extension

8.9.6.1. Company Overview

8.9.6.2. Financial Performance

8.9.6.3. Product Portfolios

8.9.6.4. Strategic Initiatives

8.9.7. Wonderfeel

8.9.7.1. Company Overview

8.9.7.2. Financial Performance

8.9.7.3. Product Portfolios

8.9.7.4. Strategic Initiatives

8.9.8. Nutricost

8.9.8.1. Company Overview

8.9.8.2. Financial Performance

8.9.8.3. Product Portfolios

8.9.8.4. Strategic Initiatives

8.9.9. RENUE BY SCIENCE, Inc.

8.9.9.1. Company Overview

8.9.9.2. Financial Performance

8.9.9.3. Product Portfolios

8.9.9.4. Strategic Initiatives

8.9.10. Codeage LLC

8.9.10.1. Company Overview

8.9.10.2. Financial Performance

8.9.10.3. Product Portfolios

8.9.10.4. Strategic Initiatives

8.9.11. HPN SUPPLEMENTS

8.9.11.1. Company Overview

8.9.11.2. Financial Performance

8.9.11.3. Product Portfolios

8.9.11.4. Strategic Initiatives

List of Tables

Table 1 Global nicotinamide adenine dinucleotide (NAD) products market – Key market driver analysis

Table 2 Global nicotinamide adenine dinucleotide (NAD) products market – Key market restraint analysis

Table 3 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by product (USD Million)

Table 4 Global nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 5 U.S macro-economic outlay

Table 6 U.S nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 7 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 8 U.S nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 9 Canada macro-economic outlay

Table 10 Canada nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 11 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 12 Canada nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 13 Mexico macro-economic outlay

Table 14 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 15 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 16 Mexico nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 17 U.K macro-economic outlay

Table 18 U.K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 19 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 20 U.K nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 21 Germany macro-economic outlay

Table 22 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 23 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 24 Germany nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 25 France macro-economic outlay

Table 26 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 27 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 28 France nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 29 Italy macro-economic outlay

Table 30 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 31 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 32 Italy nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 33 Spain macro-economic outlay

Table 34 Spain nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 35 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 36 Spain nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 37 China macro-economic outlay

Table 38 China nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 39 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 40 China nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 41 India macro-economic outlay

Table 42 India nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 43 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 44 India nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 45 Japan macro-economic outlay

Table 46 Japan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 47 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 48 Japan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 49 Australia & New Zealand macro-economic outlay

Table 50 Australia & New Zealand Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 51 Taiwan macro-economic outlay

Table 52 Taiwan Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 53 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 54 Taiwan nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 55 South Korea macro-economic outlay

Table 56 South Korea Nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 57 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 58 South Korea nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 59 Brazil macro-economic outlay

Table 60 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 61 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 62 Brazil nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 63 UAE macro-economic outlay

Table 64 UAE nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Table 65 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by Product (USD Million)

Table 66 UAE nicotinamide adenine dinucleotide (NAD) products market estimates & forecast, by distribution channel (USD Million)

Table 67 Recent developments & impact analysis by key market participants

Table 68 Company market share, 2024

Table 69 Company heat map analysis

Table 70 Companies undergoing key strategies

List of Figures

Fig. 1 Global Nicotinamide Adenine Dinucleotide (NAD) Products Market Segmentation

Fig. 2 Information procurement

Fig. 3 Primary research pattern

Fig. 4 Primary research approaches

Fig. 5 Primary research process

Fig. 6 Market snapshot

Fig. 7 Product snapshot

Fig. 8 Distribution Channel snapshot

Fig. 9 Regional snapshot

Fig. 10 Competitive landscape snapshot

Fig. 11 Global nicotinamide adenine dinucleotide (NAD) products market size (USD Million)

Fig. 12 Global nicotinamide adenine dinucleotide (NAD) products market size, 2021 to 2033 (USD Million)

Fig. 13 Global nicotinamide adenine dinucleotide (NAD) products market: Penetration & growth prospect mapping

Fig. 14 Global nicotinamide adenine dinucleotide (NAD) products market: Value chain analysis

Fig. 15 Global nicotinamide adenine dinucleotide (NAD) products market: Profit margin analysis

Fig. 16 Global nicotinamide adenine dinucleotide (NAD) products market: Market dynamics

Fig. 17 Global nicotinamide adenine dinucleotide (NAD) products market: Porter’s five forces analysis

Fig. 18 Factors influencing buying decisions for nicotinamide adenine dinucleotide (NAD) products

Fig. 19 Global nicotinamide adenine dinucleotide (NAD) products market: Product Movement Analysis, 2024 & 2033 (%)

Fig. 20 Oral Supplements market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 21 Capsules/Tablets market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 22 Powders market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 23 Energy Drinks market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 24 Topical Products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 25 Creams & Serums market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 26 Eye Cream & Lip Balms market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 27 Others market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 28 Global nicotinamide adenine dinucleotide (NAD) products market: Distribution Channel Movement Analysis, 2024 & 2033 (%)

Fig. 29 Hypermarkets & Supermarkets nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 30 Pharmacies & Drug Stores nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 31 Online nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 32 Others nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 33 Global nicotinamide adenine dinucleotide (NAD) products market: Regional outlook, 2024 & 2033 (USD Million)

Fig. 34 Regional marketplace: Key takeaways

Fig. 35 North America market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 36 U S market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 37 Canada market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 38 Mexico market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 39 Europe nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 40 U K nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 41 Germany nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 42 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 43 France nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 44 Italy nicotinamide adenine dinucleotide (NAD) products market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 45 Spain nicotinamide adenine dinucleotide (NAD) products market estimates, 2021 – 2033 (USD Million)

Fig. 46 China market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 47 India market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 48 Japan market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 49 Australia & New Zealand market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 50 Taiwan market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 51 South Korea market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 52 Brazil market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 53 UAE market estimates and forecast, 2021 – 2033 (USD Million)

Fig. 54 Key company categorization

Fig. 55 Company market share analysis, 2024

Fig. 56 Strategic framework of nicotinamide adenine dinucleotide (NAD) products market

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧